Related Experiment Video
Updated: Mar 18, 2026
03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
1.5K
Eosinophilic Endotype of Asthma
Fernando Aleman1, Hui Fang Lim2, Parameswaran Nair3
1Division of Respirology, St Joseph's Healthcare Hamilton, McMaster University, Hamilton, Ontario, Canada.
Immunology and Allergy Clinics of North America
|July 13, 2016
Summary
Eosinophilic asthma is a specific type of asthma defined by high eosinophil levels and response to treatments. Diagnosis often relies on blood or sputum eosinophil counts, as invasive airway biopsies are impractical.
Area of Science:
- Pulmonology
- Immunology
- Allergy
Background:
- Asthma is a complex respiratory condition with diverse clinical presentations.
- Classification into endotypes aids in understanding disease mechanisms and guiding treatment.
- Eosinophilic asthma is a key endotype characterized by specific inflammatory pathways.
Purpose of the Study:
- To define the eosinophilic endotype of asthma.
- To outline diagnostic criteria for eosinophilic asthma.
- To discuss the clinical relevance of eosinophil-driven inflammation.
Main Methods:
- Review of existing literature on asthma endotypes.
- Analysis of diagnostic markers for eosinophilic inflammation.
- Discussion of treatment responses related to eosinophilia.
Main Results:
- Eosinophilic asthma is characterized by elevated eosinophils in sputum and/or blood.
- Patients with this endotype show significant improvement with treatments targeting eosinophils.
- Histopathological confirmation of airway eosinophils is definitive but invasive.
Conclusions:
- Eosinophilic asthma represents a distinct clinical entity.
- Non-invasive markers like blood or sputum eosinophil counts are crucial for diagnosis.
- Understanding endotypes improves personalized asthma management.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
4.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
01:20Asthma: Pathogenesis and Management
1.6K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.6K
01:29Asthma-I: Introduction
3.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
01:30Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
01:24Asthma-III: Symptoms and Complications
3.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.6K